Are you Dr. Silva?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3525 E Louise Dr
Ste 195
Meridian, ID 83642Phone+1 208-846-8335Fax+1 208-846-8335
Summary
- Dr. Arnold Silva, MD is a nephrologist in Meridian, Idaho. He is currently licensed to practice medicine in Idaho and Arizona. He is affiliated with Saint Alphonsus Regional Medical Center, Saint Alphonsus Medical Center - Nampa, and West Valley Medical Center.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Nephrology, 1999 - 2001- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1996 - 1999
- University of Arizona College of MedicineClass of 1996
Certifications & Licensure
ID State Medical License 2005 - 2026
AZ State Medical License 2000 - 2010- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Aprima EHR, Aprima Medical Software, Inc., 2012-2013
Clinical Trials
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
- A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Start of enrollment: 2017 Mar 02
Publications & Presentations
PubMed
- 18 citationsEfficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.Katherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney
Lancet. 2024-01-27 - 4 citationsEffects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.Dana V. Rizk, Arnold L. Silva, Pablo E. Pergola, Robert D. Toto, David G. Warnock
Cardiorenal Medicine. 2019-01-01 - 12 citationsEffects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.Glenn M. Chertow, Gerald B. Appel, Geoffrey A. Block, Melanie P. Chin, Daniel W. Coyne
Journal of Diabetes and Its Complications. 2018-12-01
Press Mentions
Reata Announces Presentation of Four Clinical Abstracts at the American Society of Nephrology Kidney Week 2018May 2nd, 2019
